SIA
IONS icon

Sit Investment Associates’s Ionis Pharmaceuticals IONS Stock Holding History

Sit Investment Associates’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-13,725
Closed -$572K – 555
2018
Q2 		$572K Hold
13,725
– – 0.01% 405
2018
Q1 		$605K Sell
13,725
-10,500
-43% -$533K 0.01% 400
2017
Q4 		$1.22M Sell
24,225
-500
-2% -$27.4K 0.03% 348
2017
Q3 		$1.25M Sell
24,725
-950
-4% -$49.8K 0.03% 331
2017
Q2 		$1.31M Sell
25,675
-450
-2% -$21K 0.03% 325
2017
Q1 		$1.05M Sell
26,125
-4,000
-13% -$180K 0.03% 352
2016
Q4 		$1.44M Hold
30,125
– – 0.04% 299
2016
Q3 		$1.1M Hold
30,125
– – 0.03% 300
2016
Q2 		$702K Sell
30,125
-8,500
-22% -$274K 0.02% 337
2016
Q1 		$1.56M Sell
38,625
-500
-1% -$20.3K 0.03% 276
2015
Q4 		$2.42M Hold
39,125
– – 0.05% 227
2015
Q3 		$1.58M Hold
39,125
– – 0.03% 278
2015
Q2 		$2.25M Sell
39,125
-2,400
-6% -$153K 0.04% 231
2015
Q1 		$2.64M Sell
41,525
-27,100
-39% -$1.84M 0.05% 222
2014
Q4 		$4.24M Sell
68,625
-5,280
-7% -$261K 0.07% 201
2014
Q3 		$2.87M Sell
73,905
-37,800
-34% -$1.34M 0.05% 232
2014
Q2 		$3.85M Hold
111,705
– – 0.07% 237
2014
Q1 		$4.83M Buy
111,705
+36,030
+48% +$1.75M 0.08% 202
2013
Q4 		$3.02M Sell
75,675
-1,900
-2% -$67.7K 0.05% 244
2013
Q3 		$2.91M Buy
+77,575
New +$2.32M 0.06% 236

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Sit Investment Associates's IONS Position: Q3 2018 in Review

Sit Investment Associates sold out of Ionis Pharmaceuticals (IONS) in Q3 2018, closing a stake of 13,725 shares — an estimated $572K sold.

Sit Investment Associates first reported a position in IONS in Q3 2013 and held it in 20 quarters. The position peaked at $4.83M in Q1 2014. 322 funds tracked by Wall St. Rank hold IONS as of Q3 2018.

  • Sit Investment Associates reported no remaining Ionis Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
  • Sit Investment Associates sold 13,725 Ionis Pharmaceuticals shares in Q3 2018, an estimated $572K.
  • Sit Investment Associates first reported a position in Ionis Pharmaceuticals in Q3 2013 and held it in 20 quarters.
  • Sit Investment Associates's Ionis Pharmaceuticals position peaked at $4.83M in Q1 2014.
  • 322 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2018.

Based on Sit Investment Associates's 13F filing for Q3 2018, filed 14 Nov 2018.